Sanjivani Paranteral Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 328426, "name": "Sanjiv.Parant.", "stock_name": "Sanjiv.Parant.", "full_name": "Sanjivani Paranteral Ltd", "name_url": "stocks-analysis/sanjivparant", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "175.95", "chg": 4.55, "chgp": "2.65%", "dir": 1, "prev_price": "171.40", "mcapval": "216.14 Cr", "mcap": "Micro Cap", "scripcode": 531569, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE860D01013", "curr_date": "Sep 23, 03:29 PM", "curr_time": "15:30 PM", "last_traded_at": "Sep 23, 03:29 PM IST", "bse_nse_vol": "4.65 k", "exc_status": "Active", "traded_date": "Sep 23, 2026", "traded_date_str": "2026 09 23", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Sanjivani Paranteral Ltd Forms Golden Cross Amid Mixed Technical Signals and Declining Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-forms-golden-cross-indicating-potential-bullish-breakout-4200121", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SanjivaniParant_goldencross_4200121.png", "date": "2026-09-21 18:00:14", "description": "The 50-day moving average has crossed above the 200-day moving average for Sanjivani Paranteral Ltd, signalling a golden cross on 21 Sep 2026. Yet, the stock declined 2.95% on the day the cross formed, while monthly technical indicators remain bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal’s reliability." }, { "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Price Attractiveness Change", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-price-attractiveness-change-4196618", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SanjivaniParant_valuationdot_4196618.png", "date": "2026-09-18 08:00:18", "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from fair to expensive territory. This change, reflected in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals evolving market sentiment amid mixed returns and peer comparisons." }, { "title": "Sanjivani Paranteral Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-hold-by-marketsmojo-4192427", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SanjivaniParant_mojoScore_4192427.png", "date": "2026-09-14 10:10:32", "description": "Sanjivani Paranteral Ltd is rated Hold by MarketsMOJO, with this rating last updated on 17 August 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 14 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-renewed-price-attractiveness-4189659", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SanjivaniParant_valuationdot_4189659.png", "date": "2026-09-11 08:00:13", "description": "Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, reflecting a more attractive price point for investors amid a challenging market backdrop. This re-rating comes alongside a recent upgrade in its Mojo Grade from Sell to Hold, signalling cautious optimism in the pharmaceuticals and biotechnology sector." }, { "title": "Sanjivani Paranteral Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-hold-by-marketsmojo-4175991", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanjivaniParant_mojoScore_4175991.png", "date": "2026-08-31 10:10:39", "description": "Sanjivani Paranteral Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 August 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook." }, { "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-renewed-price-attractiveness-4175229", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanjivaniParant_valuationdot_4175229.png", "date": "2026-08-31 08:00:14", "description": "Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change, coupled with its improving mojo grade from Sell to Hold, highlights a renewed price attractiveness for investors amid a challenging pharmaceutical sector backdrop." }, { "title": "Sanjivani Paranteral Ltd’s Volatile Week: -1.12% Amid Quality Upgrade and Mixed Market Moves", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltds-volatile-week--112-amid-quality-upgrade-and-mixed-market-moves-4165800", "imagepath": "", "date": "2026-08-23 10:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>17 Aug:</strong> Strong quarterly turnaround reported with highest-ever revenue and margin expansion</p>\n <p><strong>18 Aug:</strong> Quality grade upgraded from average to good, signalling improved fundamentals</p>\n <p><strong>18 Aug:</strong> Investment rating upgraded from Sell to Hold by MarketsMOJO</p>\n <p><strong>21 Aug:</strong> Week closes at Rs.193.40, down 1.12% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.192.35</div></div>\n <div class=\"stat-item\"><div ..." }, { "title": "Sanjivani Paranteral Ltd Upgraded to Hold as Financial and Quality Metrics Improve", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-upgraded-to-hold-as-financial-and-quality-metrics-improve-4158708", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanjivaniParant_mojoScore_4158708.png", "date": "2026-08-18 08:02:31", "description": "Sanjivani Paranteral Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across financial performance, quality metrics, valuation, and technical indicators. The pharmaceutical micro-cap’s recent quarterly results and long-term fundamentals have prompted a reassessment of its outlook, signalling cautious optimism for investors amid mixed market returns." }, { "title": "Sanjivani Paranteral Ltd Quality Grade Upgrade Signals Strengthening Fundamentals", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-quality-grade-upgrade-signals-strengthening-fundamentals-4158422", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanjivaniParant_qualitydot_4158422.png", "date": "2026-08-18 08:00:11", "description": "Sanjivani Paranteral Ltd has seen its quality rating upgraded from average to good, reflecting notable improvements in key business fundamentals such as return on equity (ROE), return on capital employed (ROCE), and debt management. Despite a recent dip in share price and mixed short-term returns, the company’s long-term performance and financial health indicate a strengthening position within the Pharmaceuticals & Biotechnology sector." } ], "total": 262, "sid": "328426", "stock_news_url": "https://www.marketsmojo.com/news/sanjivani-paranteral-328426" }, "announcements": [ { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "16-Sep-2026", "details": "Scrutinizer Report for the Annual General Meeting held on 16th September 2026", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM", "datetime": "16-Sep-2026", "details": "Proceeding and Outcome of 32nd Annual General Meeting of the Company", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "26-Aug-2026", "details": "Newspaper Advertisment of 32nd Annual general Meeting notice In accordance with Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Sanjivani Paranteral Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 25", "dt": "2025-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

17 Aug: Strong quarterly turnaround reported with highest-ever revenue and margin expansion

18 Aug: Quality grade upgraded from average to good, signalling improved fundamentals

18 Aug: Investment rating upgraded from Sell to Hold by MarketsMOJO

21 Aug: Week closes at Rs.193.40, down 1.12% for the week

Week Open

Rs.192.35

Read full news article

Sanjivani Paranteral Ltd Upgraded to Hold as Financial and Quality Metrics Improve

2026-08-18 08:02:31

Sanjivani Paranteral Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across financial performance, quality metrics, valuation, and technical indicators. The pharmaceutical micro-cap’s recent quarterly results and long-term fundamentals have prompted a reassessment of its outlook, signalling cautious optimism for investors amid mixed market returns.

Read full news article

Sanjivani Paranteral Ltd Quality Grade Upgrade Signals Strengthening Fundamentals

2026-08-18 08:00:11

Sanjivani Paranteral Ltd has seen its quality rating upgraded from average to good, reflecting notable improvements in key business fundamentals such as return on equity (ROE), return on capital employed (ROCE), and debt management. Despite a recent dip in share price and mixed short-term returns, the company’s long-term performance and financial health indicate a strengthening position within the Pharmaceuticals & Biotechnology sector.

Read full news article